123 related articles for article (PubMed ID: 511372)
21. Influence of charcoal haemoperfusion on platelet count in acute poisoning and during regular dialysis treatment.
Mydlík M; Bucek J; Derzsiová K; Jarcuska J; Takác M
Int Urol Nephrol; 1981; 13(4):387-9. PubMed ID: 7343540
[TBL] [Abstract][Full Text] [Related]
22. Hemoperfusion in chronic uremia.
Stefoni S; Feliciangeli G; Cianciolo G; De Sanctis LB; Giardino R; Spighi M
Boll Soc Ital Biol Sper; 1993 Nov; 69(11):675-82. PubMed ID: 8060597
[TBL] [Abstract][Full Text] [Related]
23. Influence of hemoperfusion using polyetherurethane sheet embedded with powdered charcoal (UPC) on middle molecules of hepatic failure dogs.
Kawanishi H; Nishiki M; Kanao M; Nakagawa K; Sugiyama M; Tsuchiya T; Ezaki H
Hiroshima J Med Sci; 1984 Dec; 33(4):633-8. PubMed ID: 6534919
[No Abstract] [Full Text] [Related]
24. Charcoal hemoperfusion. Plus ça change, plus c'est la même chose.
Berk PD; Goldberg JD
Gastroenterology; 1988 May; 94(5 Pt 1):1228-30. PubMed ID: 3350293
[No Abstract] [Full Text] [Related]
25. Clinical evaluation of the clearance profiles of a portable, compact, dialysate-free system incorporating microencapsulated charcoal hemoperfusion for blood purification with ultrafiltration for fluid removal.
Chang TM; Chirito E; Barre P; Cole C; Lister C; Resurreccion E
J Dial; 1977; 1(3):239-59. PubMed ID: 614387
[TBL] [Abstract][Full Text] [Related]
26. Effects of charcoal hemoperfusion with prostacyclin on the coagulation-fibrinolysis system and platelets of patients with fulminant hepatic failure--preliminary observations.
Cordopatri F; Boncinelli S; Marsili M; Lorenzi P; Fabbri LP; Paci P; Salvadori M; Morfini M; Cinotti S; Casparini P
Int J Artif Organs; 1982 Jul; 5(4):243-7. PubMed ID: 6749697
[No Abstract] [Full Text] [Related]
27. [Hemoperfusion by means of encapsuled charcoal for the treatment of exogenous and endogenous intoxications].
Lesche P; Blume U; Scheibe G; Sussmann P; Schmidt FW; Bartels M; Okonek S
Klin Wochenschr; 1976 Jun; 54(11):509-16. PubMed ID: 933456
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of a new coated charcoal for hemoperfusion in uremia.
Stefoni S; Feliciangeli G; Coli L; Bonomini V
Int J Artif Organs; 1979 Nov; 2(6):320-3. PubMed ID: 511374
[TBL] [Abstract][Full Text] [Related]
29. A combined charcoal-resin hemoperfusion system in acute experimental hepatic failure in pigs. Depurative activity on plasma amino acids.
Marrano D; Plicchi G; Liguori L; Marchesini G; Campione O; Spighi M; Roversi CA; Betti V; Vatrella S; Melli A
Life Support Syst; 1983; 1 Suppl 1():74-7. PubMed ID: 6336465
[No Abstract] [Full Text] [Related]
30. Comparison of a charcoal sorbent fiber with commercial charcoals for hemoperfusion.
Gundermann KJ; Uhlhaas S; Grünn U; Olek K; Ukigusa M; Lie TS
Artif Organs; 1983 May; 7(2):186-96. PubMed ID: 6870596
[TBL] [Abstract][Full Text] [Related]
31. Biochemical correlates of reversal of hepatic coma coated with charcoal hemoperfusion.
Gelfand MC; Winchester JF; Knepshield JH; Cohan SL; Schreiner GE
Trans Am Soc Artif Intern Organs; 1978; 24():239-42. PubMed ID: 716005
[TBL] [Abstract][Full Text] [Related]
32. Effects of hemoperfusion rate and time of initiation of ACAC charcoal hemoperfusion on the survival of fulminant hepatic failure rats.
Chang TM; Lister C; Chirito E; O'Keefe P; Resurreccion E
Trans Am Soc Artif Intern Organs; 1978; 24():243-5. PubMed ID: 716006
[No Abstract] [Full Text] [Related]
33. Effect of charcoal hemoperfusion on amino acid disturbance in experimental hepatic coma.
Shi ZQ; Chang TM
Int J Artif Organs; 1984 Jul; 7(4):203-8. PubMed ID: 6490192
[TBL] [Abstract][Full Text] [Related]
34. Coated charcoal haemoperfusion.
Chang TM
Life Support Syst; 1984; 2(2):99-106. PubMed ID: 6384672
[TBL] [Abstract][Full Text] [Related]
35. Liver support systems: the low clearance of model hepatic excretory anions by charcoal hemoperfusion.
Hew JT; Hart FE; Willson RA
Gastroenterology; 1978 Apr; 74(4):661-3. PubMed ID: 631502
[TBL] [Abstract][Full Text] [Related]
36. Soluble liver extract as supplement to detoxification by hemoperfusion in liver failure.
Dixit V; Chang TM
Int J Artif Organs; 1981 Nov; 4(6):291-4. PubMed ID: 7333688
[TBL] [Abstract][Full Text] [Related]
37. [Special aspects of intensive care for coma due to hepatic, renal, endocrine and toxic causes].
Schönborn H
Klin Anasthesiol Intensivther; 1979; 19():217-34. PubMed ID: 439771
[No Abstract] [Full Text] [Related]
38. Artificial cells in hemoperfusion and other applications.
Chang TM
Nephron; 1984; 36(3):161-8. PubMed ID: 6366599
[TBL] [Abstract][Full Text] [Related]
39. Hemoperfusion in the treatment of uremia.
Gurland HJ
Kidney Int Suppl; 1985 Dec; 17():S47-9. PubMed ID: 3912588
[TBL] [Abstract][Full Text] [Related]
40. The effects of hemoperfusion using coated charcoal or tyrosinase artificial cells on middle molecules and tyrosine in brain and serum of hepatic coma rats.
Shi ZQ; Chang TM
Trans Am Soc Artif Intern Organs; 1982; 28():205-9. PubMed ID: 6819667
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
